CN113795242B - 可溶解的聚合物眼睛插入物及其使用方法 - Google Patents

可溶解的聚合物眼睛插入物及其使用方法

Info

Publication number
CN113795242B
CN113795242B CN202080032297.3A CN202080032297A CN113795242B CN 113795242 B CN113795242 B CN 113795242B CN 202080032297 A CN202080032297 A CN 202080032297A CN 113795242 B CN113795242 B CN 113795242B
Authority
CN
China
Prior art keywords
insert
polymeric
eye
ocular
polymeric ocular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202080032297.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN113795242A (zh
Inventor
H·A·凯特尔森
R·兰加拉詹
W·R·拉里多
S·J·柯林斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Inc
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of CN113795242A publication Critical patent/CN113795242A/zh
Application granted granted Critical
Publication of CN113795242B publication Critical patent/CN113795242B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN202080032297.3A 2019-05-02 2020-05-01 可溶解的聚合物眼睛插入物及其使用方法 Active CN113795242B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962841901P 2019-05-02 2019-05-02
US62/841,901 2019-05-02
US201962927885P 2019-10-30 2019-10-30
US62/927,885 2019-10-30
PCT/IB2020/054148 WO2020222195A1 (en) 2019-05-02 2020-05-01 Dissolvable polymeric eye inserts and method of using same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202610730188.8A Division CN122604686A (zh) 2019-05-02 2020-05-01 可溶解的聚合物眼睛插入物及其使用方法

Publications (2)

Publication Number Publication Date
CN113795242A CN113795242A (zh) 2021-12-14
CN113795242B true CN113795242B (zh) 2026-06-16

Family

ID=70554143

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080032297.3A Active CN113795242B (zh) 2019-05-02 2020-05-01 可溶解的聚合物眼睛插入物及其使用方法

Country Status (12)

Country Link
US (1) US12102559B2 (cg-RX-API-DMAC7.html)
EP (1) EP3962450A1 (cg-RX-API-DMAC7.html)
JP (1) JP7350885B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220004969A (cg-RX-API-DMAC7.html)
CN (1) CN113795242B (cg-RX-API-DMAC7.html)
AU (1) AU2020266339B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021019774A2 (cg-RX-API-DMAC7.html)
CA (1) CA3137417C (cg-RX-API-DMAC7.html)
MX (1) MX2021013428A (cg-RX-API-DMAC7.html)
SG (1) SG11202110514RA (cg-RX-API-DMAC7.html)
TW (1) TWI826685B (cg-RX-API-DMAC7.html)
WO (1) WO2020222195A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017062770A1 (en) 2015-10-08 2017-04-13 Silverberg Noah Punctal plug and bioadhesives
US12491263B2 (en) 2019-05-13 2025-12-09 University of Pittsburgh—of the Commonwealth System of Higher Education Polymer-based implant for retinal therapy and methods of making and using the same
CN115066232B (zh) 2020-02-06 2024-12-10 视尔普斯眼科公司 用于治疗眼病的组合物和方法
EP4142664A4 (en) 2020-04-27 2024-05-29 Ocular Therapeutix, Inc. METHODS FOR TREATING ALLERGIC CONJUNCTIVITIS
EP4432990A4 (en) * 2021-11-16 2025-07-30 Univ Pittsburgh Commonwealth Sys Higher Education POLYMER-BASED GEL IMPLANT FOR RETINAL THERAPY AND METHODS OF MAKING AND USING THE SAME
WO2023119231A1 (en) * 2021-12-23 2023-06-29 Alcon Inc. Dissolvable medical device and kit for corneal surface protection
WO2023119235A1 (en) * 2021-12-23 2023-06-29 Alcon Inc. Dissolvable medical device for promoting healing of wounds
TW202339703A (zh) * 2021-12-23 2023-10-16 瑞士商愛爾康公司 用於藥物遞送的可溶解醫療裝置
WO2023214027A1 (en) * 2022-05-06 2023-11-09 Eyed Pharma Insert for the treatment of dry eyes
US20240207174A1 (en) * 2022-12-23 2024-06-27 Alcon Inc. Dissolvable polymeric eye inserts
WO2024180472A1 (en) * 2023-02-28 2024-09-06 Alcon Inc. Ocular inserts
WO2024180453A1 (en) * 2023-02-28 2024-09-06 Alcon Inc. Dissolvable polymeric eye inserts with a non-ionic cellulose derivative

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4730013A (en) * 1981-10-08 1988-03-08 Merck & Co., Inc. Biosoluble ocular insert

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT75625B (en) 1981-10-08 1985-12-09 Merck & Co Inc Process for preparing biosoluble ocular insert
ATE240698T1 (de) 1995-06-07 2003-06-15 Keravision Inc Radiales intrastromales hornhautimplantat
CA2602525A1 (en) 2005-03-21 2006-09-28 Macusight, Inc. Drug delivery systems for treatment of diseases or conditions
EP1973421A2 (en) * 2005-12-23 2008-10-01 Cadbury Adams USA LLC Compositions providing a sensation substantially similar to that provided by menthol
KR101555291B1 (ko) 2007-02-09 2015-09-30 알콘, 인코퍼레이티드 세가지 폴리머의 상승성 배합물을 함유하는 안과 조성물
US20130244978A1 (en) * 2007-09-14 2013-09-19 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition
US20130172357A1 (en) * 2011-02-03 2013-07-04 Eye Therapies Llc Compositions and Methods for Treatment of Glaucoma
US20120215184A1 (en) 2011-02-18 2012-08-23 Valeant International (Barbados) Srl Cylindrical ocular inserts
US20140107025A1 (en) 2012-04-16 2014-04-17 Jade Therapeutics, Llc Ocular drug delivery system
UA113434C2 (uk) 2012-05-04 2017-01-25 Алкон Рісерч, Лтд. Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням
RU2683651C2 (ru) 2013-06-18 2019-04-01 Иван Дмитриевич Захаров Лекарственное средство для лечения кератоконуса и других дегенеративных заболеваний роговицы и фармацевтические препараты на его основе
US9782345B2 (en) 2013-10-17 2017-10-10 Jade Therapeutics, Inc. Ocular composition and method
CA2947274C (en) * 2014-04-28 2019-03-19 Hampton Technologies Ophthalmic compositions and methods for treating eyes
JP6200108B2 (ja) 2014-06-20 2017-09-20 クーパーヴィジョン インターナショナル ホウルディング カンパニー リミテッド パートナーシップ 眼感染症の治療のための眼科用組成物
US9931306B2 (en) 2014-09-06 2018-04-03 Integral Biosystems Llc Methods and biocompatible compositions to achieve sustained drug release in the eye

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4730013A (en) * 1981-10-08 1988-03-08 Merck & Co., Inc. Biosoluble ocular insert

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid;Marco F. Saettone;《International Journal of Pharmaceutics》;第51卷(第3期);第203-212 *
Formulation and In Vitro-In Vivo Correlation of Timolol Maleate Ocular Insert;Sunil Thakral;《Indonesian Journal of Clinical Pharmacy》;第4卷(第4期);第281–288页 *

Also Published As

Publication number Publication date
CA3137417A1 (en) 2020-11-05
WO2020222195A1 (en) 2020-11-05
TW202106286A (zh) 2021-02-16
US20200345544A1 (en) 2020-11-05
JP7350885B2 (ja) 2023-09-26
AU2020266339B2 (en) 2023-12-07
JP2022530758A (ja) 2022-07-01
AU2020266339A1 (en) 2021-12-23
KR20220004969A (ko) 2022-01-12
TWI826685B (zh) 2023-12-21
US12102559B2 (en) 2024-10-01
EP3962450A1 (en) 2022-03-09
CA3137417C (en) 2024-01-09
CN113795242A (zh) 2021-12-14
BR112021019774A2 (pt) 2021-12-07
MX2021013428A (es) 2021-12-10
SG11202110514RA (en) 2021-11-29

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant